Advanced search
Publication Cover
Cell Cycle Volume 13, 2014 - Issue 6
Submit an article Journal homepage
1,076
Views
25
CrossRef citations to date
0
Altmetric
Report

The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target

Lu-Zhe Pan Department of Microbiology and Immunology; Dalhousie University; Halifax, Nova Scotia, Canada
,
Dae-Gyun Ahn Department of Microbiology and Immunology; Dalhousie University; Halifax, Nova Scotia, Canada
,
Tanveer Sharif Department of Microbiology and Immunology; Dalhousie University; Halifax, Nova Scotia, Canada
,
Derek Clements Department of Pathology; Dalhousie University; Halifax, Nova Scotia, Canada
,
Shashi Gujar Department of Microbiology and Immunology; Dalhousie University; Halifax, Nova Scotia, Canada; Strategy & Organizational Performance; IWK Health Centre; Halifax, Nova Scotia, Canada
&
Patrick W.K. Lee Department of Microbiology and Immunology; Dalhousie University; Halifax, Nova Scotia, Canada; Department of Pathology; Dalhousie University; Halifax, Nova Scotia, CanadaCorrespondence[email protected]
Pages 1041-1048 | Received 16 Jan 2014, Accepted 06 Feb 2014, Published online: 07 Feb 2014

Related Research Data

NMNAT2-mediated NAD+ generation is essential for quality control of aged oocytes.
Source: Wiley
TAp73 transcriptionally represses BNIP3 expression
Source: Taylor & Francis
NAD Metabolism in Cancer Therapeutics.
Source: Frontiers Media SA

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.